
Pfizer (NYSE:PFE) has reached a confidential settlement covering federal lawsuits over its Depo-Provera contraceptive and alleged intracranial meningioma risk. The agreement reportedly addresses more than 6,000 cases, with financial terms not disclosed and no admission of liability by Pfizer. The resolution closes a multi year legal overhang tied to Depo-Provera and brings clarity to a significant product liability dispute. This kind of large scale legal settlement can shift how investors...




















